← 產業報告目錄

Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Instruments (Peptide Synthesizer, Chromatography, Lyophilizer), Technique (Solid-phase, Solution-phase, Hybrid), Services, Application (Therapeutics), End User - Global Forecast to 2029

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2025-02-05頁數 564報告編號 BT6462

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global peptide synthesis market is projected to surpass USD 1.41 billion in 2029 from USD 0.81 billion in 2024, with a significant CAGR of 11.7%. The peptide synthesis market is driven by several factors such as advancements in technology, increasing research in drug discovery, and the growing demand for personalized medicine. Additionally, the rising prevalence of chronic diseases such as cancer and diabetes is fueling demand for therapeutic peptides in targeted therapies further propelling the growth of the market. “Resins and Amino acids accounted for the dominant share in the reagents market” Based on offerings (products & services), products (Consumables and Instruments), consumables (Reagents and Other Consumables), Reagents (Resins, Amino Acids, Coupling Reagents, Dyes and Fluorescent Labelling Reagents, Deprotection Reagents, Cleavage Reagents and Other Reagents), Instruments (Peptide Synthesizers (automated and manual), Chromatography Equipment, Lyophilizers and Others). Resins form the foundation of solid-phase peptide synthesis (SPPS), serving as a stable platform for the stepwise construction of peptide chains. Advancements in resins such as preloaded resins and specialized linkers are likely to impact positively on the market. “Peptide synthesis services dominated the market” The services segment is further segmented into peptide library synthesis, peptide synthesis, peptide purification services, and peptide analysis services. Peptide synthesis services dominated the market due to their ability to meet the increasing demand for custom and complex peptides required in drug discovery, therapeutic development, and research applications. Additionally, the rise of personalized medicine and peptide-based vaccines has increased the demand for custom synthesis driving the segmental growth. “Therapeutics segment dominated the application segment in 2023” Applications segment is divided into Therapeutics, Diagnostics and Research & Development. Therapeutics by Indications (Cancer, Diabetes, Obesity, Autoimmune Disease and Other Disease Indication), Therapeutics by Molecules (Peptide-Based Vaccines, Peptide-Drug Conjugates (PDCs), Peptide Inhibitors and Other Molecules). Advancements in peptide synthesis technologies, such as solid-phase peptide synthesis (SPPS) and recombinant DNA methods, has enabled the efficient production of high-purity, cost-effective peptides for vaccine development. The growing focus on personalized immunotherapies and increased investment in peptide-based vaccine research further reinforce their leading position in the market. “North America: the largest share of the peptide synthesis market” The market is segmented by region into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America dominated the peptide synthesis market in 2023 and is estimated to continue dominance during the forecast period. US leads the North American market, driven by the strong presence of key players like Thermo Fisher Scientific and CEM Corporation, with substantial funding for biomedical research and innovation in peptide-based therapeutics. Europe holds a significant share of the market, with countries like Germany, and UK being major contributors. This dominance attributed to strong R&D activities, collaborations between academic institutions and industry, and a growing focus on personalized medicine and peptide-based drugs. In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the peptide synthesis market. The primary interviews conducted for this report can be categorized as follows: • By Respondent: Tier 1- 45%, Tier 2- 35%, Tier 3- 20% • By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25% • By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5% Bachem Holding AG (Switzerland), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), GenScript (China), and CEM Corporation (US) are some of the major players operating in the peptide synthesis market. Research Coverage: This research report categorizes the peptide synthesis market offerings (products & services), products (Consumables and Instruments), consumables (Reagents and Other Consumables), Reagents (Resins, Amino Acids, Coupling Reagents, Dyes and Fluorescent Labelling Reagents, Deprotection Reagents, Cleavage Reagents and Other Reagents), Instruments (Peptide Synthesizers (automated and manual), Chromatography Equipment, Lyophilizers and Others). Services (Peptide Library Synthesis, Peptide Synthesis, Peptide Purification Services and Peptide Analysis Services), Technique (Chemical (Solid Phase Peptide Synthesis, Solution Phase peptide synthesis and Other Chemical Methods and Biological (Recombinant DNA Technology and Enzymes), Applications (Therapeutics, Diagnostics and Research & Development), Therapeutics by Indications (Cancer, Diabetes, Obesity, Autoimmune Disease and Other Disease Indication), Therapeutics by Molecules (Peptide-Based Vaccines, Peptide-Drug Conjugates (PDCs), Peptide Inhibitors and Other Molecules), End User (Pharmaceutical and biotechnology companies, CDMOs & CROs, Academic & Research Institutes, Medical Device Companies and Hospitals and Diagnostic Centers). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the peptide synthesis market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the peptide synthesis market. Key Benefits of Buying the Report: The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the peptide synthesis and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges. The report provides insights on the following pointers: • Analysis of key drivers (advancements in peptide therapeutics, technological advancements, growing use of peptides in diagnostics and research), restraints (Regulatory Hurdles, High cost of peptide synthesis and instruments), opportunities (Adoption of personalized medicine, Rise in strategic collaborations and partnerships) and Challenges (Addressing Immunogenicity, Environmental Concerns) influencing the growth of the market. • Product/Service Development/Innovation: Detailed insights on upcoming technologies in peptide synthesis manufacturing, research and development activities, and new product/service launches in the peptide synthesis market. • Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions. • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the peptide synthesis market • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product & service offerings of leading players Thermo Fisher Scientific, Inc. (US), Bachem Holding AG (Switzerland), Kaneka Corporation (US), Inc. and Merck KGaA (Germany), among others.
目錄 Table of Contents
1 INTRODUCTION 54 1.1 STUDY OBJECTIVES 54 1.2 MARKET DEFINITION 54 1.3 STUDY SCOPE 55 1.3.1 MARKETS COVERED 55 1.3.2 REGIONAL SCOPE 56 1.3.3 INCLUSIONS AND EXCLUSIONS 56 1.3.4 YEARS CONSIDERED 57 1.4 CURRENCY CONSIDERED 57 1.5 STAKEHOLDERS 57 1.6 SUMMARY OF CHANGES 58 2 RESEARCH METHODOLOGY 59 2.1 RESEARCH DATA 59 2.1.1 SECONDARY RESEARCH 60 2.1.2 PRIMARY RESEARCH 61 2.2 MARKET SIZE ESTIMATION METHODOLOGY 62 2.2.1 GLOBAL MARKET ESTIMATION 62 2.2.2 INSIGHTS FROM PRIMARY EXPERTS 65 2.2.3 SEGMENTAL MARKET ESTIMATION (TOP-DOWN APPROACH) 65 2.3 GROWTH RATE PROJECTIONS 67 2.4 DATA TRIANGULATION 69 2.5 RESEARCH ASSUMPTIONS 70 2.6 RESEARCH LIMITATIONS 71 2.7 RISK ANALYSIS 71 3 EXECUTIVE SUMMARY 72 4 PREMIUM INSIGHTS 78 4.1 PEPTIDE SYNTHESIS MARKET OVERVIEW 78 4.2 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT TYPE AND COUNTRY, 2023 79 4.3 PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024 VS. 2029 79 4.4 PEPTIDE SYNTHESIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 80   5 MARKET OVERVIEW 81 5.1 INTRODUCTION 81 5.2 MARKET DYNAMICS 81 5.2.1 DRIVERS 82 5.2.1.1 Advancements in peptide therapeutics 82 5.2.1.2 Innovations in peptide synthesis instruments 83 5.2.1.3 Growing use of peptides in diagnostics and research 83 5.2.2 RESTRAINTS 84 5.2.2.1 Regulatory hurdles 84 5.2.2.2 High cost of peptide synthesis and instruments 84 5.2.3 OPPORTUNITIES 85 5.2.3.1 Adoption of personalized medicine 85 5.2.3.2 Strategic collaborations and partnerships 85 5.2.4 CHALLENGES 86 5.2.4.1 Immunogenicity issues 86 5.2.4.2 Environmental concerns 86 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 87 5.4 PRICING ANALYSIS 87 5.4.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 88 5.4.2 AVERAGE SELLING PRICE TREND, BY REGION 91 5.5 SUPPLY CHAIN ANALYSIS 93 5.6 VALUE CHAIN ANALYSIS 94 5.7 ECOSYSTEM ANALYSIS 97 5.7.1 PEPTIDE SYNTHESIS MARKET: PRODUCT MANUFACTURERS 97 5.7.2 PEPTIDE SYNTHESIS MARKET: SERVICE PROVIDERS 98 5.7.3 PEPTIDE SYNTHESIS MARKET: END USERS 98 5.7.4 PEPTIDE SYNTHESIS MARKET: REGULATORY BODIES 99 5.8 INVESTMENT AND FUNDING SCENARIO 99 5.9 TECHNOLOGY ANALYSIS 100 5.9.1 KEY TECHNOLOGIES 100 5.9.1.1 Solid-phase peptide synthesis (SPPS) 100 5.9.1.2 Liquid-phase peptide synthesis (LPPS) 100 5.9.1.3 Enzymatic peptide synthesis 101 5.9.1.4 Continuous-flow peptide synthesis 101 5.9.2 COMPLEMENTARY TECHNOLOGIES 101 5.9.2.1 Labeling and tracking technologies 101 5.9.2.2 Purification techniques 102 5.9.3 ADJACENT TECHNOLOGIES 102 5.9.3.1 Cell-free protein synthesis 102 5.9.3.2 Protein design and engineering 102 5.10 PATENT ANALYSIS 103 5.11 TRADE ANALYSIS 105 5.11.1 TRADE DATA FOR HS CODE 902720 (CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS) 105 5.11.1.1 Import data for HS code 902720 105 5.11.1.2 Export data for HS CODE 902720 106 5.11.2 TRADE DATA FOR HS CODE 841933 (LYOPHILISATION APPARATUS, FREEZE DRYING UNITS AND SPRAY DRYERS) 106 5.11.2.1 Import data for HS code 841993 106 5.11.2.2 Export data for HS code 841933 107 5.12 KEY CONFERENCES AND EVENTS, 2025–2026 107 5.13 REGULATORY LANDSCAPE 108 5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 109 5.13.2 REGULATORY FRAMEWORK 112 5.13.2.1 North America 112 5.13.2.1.1 US 112 5.13.2.1.2 Canada 112 5.13.2.2 Europe 112 5.13.2.2.1 Germany 112 5.13.2.2.2 UK 112 5.13.2.2.3 France 112 5.13.2.3 Asia Pacific 113 5.13.2.3.1 Japan 113 5.13.2.3.2 China 113 5.13.2.4 Latin America 113 5.13.2.4.1 Brazil 113 5.13.2.5 Middle East & Africa 113 5.13.2.5.1 GCC Countries 113 5.13.2.5.2 South Africa 113 5.14 PORTER’S FIVE FORCES ANALYSIS 114 5.14.1 BARGAINING POWER OF SUPPLIERS 115 5.14.2 BARGAINING POWER OF BUYERS 115 5.14.3 THREAT OF NEW ENTRANTS 115 5.14.4 THREAT OF SUBSTITUTES 115 5.14.5 INTENSITY OF COMPETITIVE RIVALRY 116 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA 116 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 116 5.15.2 BUYING CRITERIA 117 5.16 IMPACT OF AI/GENERATIVE AI ON PEPTIDE SYNTHESIS MARKET 119 5.16.1 INTRODUCTION 119 5.16.2 IMPACT OF AI ON PEPTIDE SYNTHESIS ECOSYSTEM 120 5.16.3 FUTURE OF GENERATIVE AI IN PEPTIDE SYNTHESIS ECOSYSTEM 121 6 PEPTIDE SYNTHESIS MARKET, BY OFFERING 122 6.1 INTRODUCTION 123 6.2 PRODUCTS 123 6.2.1 INCREASING ADOPTION OF SOLID AND LIQUID-PHASE PEPTIDE SYNTHESIS TO STIMULATE GROWTH 123 6.3 SERVICES 127 6.3.1 GROWING ADVANCEMENTS IN PEPTIDE DESIGN AND SYNTHESIS OPTIMIZATION TO FUEL MARKET 127 7 PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE 130 7.1 INTRODUCTION 131 7.2 CONSUMABLES 131 7.2.1 REAGENTS 135 7.2.1.1 Resins 138 7.2.1.1.1 Growing demand for therapeutic peptides to boost market 138 7.2.1.2 Amino acids 141 7.2.1.2.1 Increasing advancements in synthetic amino acid modifications to aid growth 141 7.2.1.3 Coupling reagents 144 7.2.1.3.1 Rising adoption of high-throughput peptide synthesis to expedite growth 144 7.2.1.4 Dyes & fluorescent labeling reagents 147 7.2.1.4.1 Increasing demand for high-resolution, sensitive imaging technologies to promote growth 147 7.2.1.5 Deprotection reagents 150 7.2.1.5.1 Rising complexity of modified peptides and cyclic structures to facilitate growth 150 7.2.1.6 Cleavage reagents 153 7.2.1.6.1 Increasing use of complex peptides to sustain growth 153 7.2.1.7 Other reagents 156 7.2.2 OTHER CONSUMABLES 159 7.3 INSTRUMENTS 162 7.3.1 PEPTIDE SYNTHESIZERS 165 7.3.1.1 Automated peptide synthesizers 169 7.3.1.1.1 Increasing launches of automated peptide synthesizers to promote growth 169 7.3.1.2 Manual peptide synthesizers 172 7.3.1.2.1 Growing use of peptide synthesizers for early-stage drug discovery and research to fuel market 172 7.3.2 CHROMATOGRAPHY SYSTEMS 175 7.3.2.1 Increasing shift toward high-throughput and industrial-scale peptide production to amplify growth 175   7.3.3 LYOPHILIZERS 178 7.3.3.1 Rising influence of contract manufacturing organizations to encourage growth 178 7.3.4 OTHER INSTRUMENTS 181 8 PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE 185 8.1 INTRODUCTION 186 8.2 PEPTIDE SYNTHESIS 186 8.2.1 RISING ADOPTION OF PERSONALIZED MEDICINES AND TARGETED THERAPIES TO INTENSIFY GROWTH 186 8.3 PEPTIDE PURIFICATION SERVICES 190 8.3.1 GROWING EMPHASIS ON HIGH-QUALITY PEPTIDES IN PHARMACEUTICAL DEVELOPMENT AND BIOTECH TO DRIVE MARKET 190 8.4 PEPTIDE LIBRARY SYNTHESIS 193 8.4.1 INCREASING FOCUS ON SYNTHETIC BIOLOGY TO AUGMENT GROWTH 193 8.5 PEPTIDE ANALYSIS SERVICES 196 8.5.1 INCREASING ADVANCEMENTS IN MASS SPECTROMETRY AND CHROMATOGRAPHY TO BOLSTER GROWTH 196 9 PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE 200 9.1 INTRODUCTION 201 9.2 CHEMICAL METHODS 201 9.2.1 SOLID-PHASE PEPTIDE SYNTHESIS 205 9.2.1.1 Increasing use of peptides and peptide derivatives in modern medicines use to encourage growth 205 9.2.2 LIQUID-PHASE PEPTIDE SYNTHESIS 208 9.2.2.1 Growing advancements in purification technologies to boost market 208 9.2.3 OTHER CHEMICAL METHODS 211 9.3 BIOLOGICAL METHODS 215 9.3.1 RECOMBINANT DNA TECHNOLOGY 218 9.3.1.1 Increasing innovations in genetic engineering and synthetic biology to drive market 218 9.3.2 ENZYMATIC SYNTHESIS 222 9.3.2.1 Growing shift toward sustainable and eco-friendly manufacturing to propel market 222 10 PEPTIDE SYNTHESIS MARKET, BY APPLICATION 225 10.1 INTRODUCTION 226 10.2 THERAPEUTIC APPLICATIONS 226 10.2.1 THERAPEUTIC APPLICATIONS, BY INDICATION 230 10.2.1.1 Cancer 230 10.2.1.1.1 Rising clinical trials to contribute to growth 230 10.2.1.2 Diabetes 233 10.2.1.2.1 Increasing need for diabetes management to favor growth 233 10.2.1.3 Obesity 236 10.2.1.3.1 Increasing development of next-generation weight management therapies to foster growth 236 10.2.1.4 Autoimmune diseases 239 10.2.1.4.1 Growing prevalence of rheumatoid arthritis, lupus, and multiple sclerosis to fuel market 239 10.2.1.5 Other diseases 243 10.2.2 THERAPEUTIC APPLICATIONS, BY MOLECULE 246 10.2.2.1 Peptide-based vaccines 246 10.2.2.1.1 Increasing research on infectious diseases and cancer immunotherapy to augment growth 246 10.2.2.2 Peptide-drug conjugates 250 10.2.2.2.1 Growing focus of pharmaceutical companies on drug conjugation to drive market 250 10.2.2.3 Peptide inhibitors 253 10.2.2.3.1 Rising traction for precision medicine to assist growth 253 10.2.2.4 Other molecules 257 10.3 DIAGNOSTIC APPLICATIONS 260 10.3.1 RISE OF PERSONALIZED MEDICINE AND POINT-OF-CARE TESTING TO ACCELERATE GROWTH 260 10.4 DISCOVERY & DEVELOPMENT APPLICATIONS 264 10.4.1 GROWING ADVANCEMENTS IN COMBINATORIAL CHEMISTRY AND HIGH-THROUGHPUT PEPTIDE LIBRARIES TO DRIVE MARKET 264 11 PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER 268 11.1 INTRODUCTION 269 11.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES 269 11.2.1 INCREASING RESEARCH ON GENOMICS AND MOLECULAR BIOLOGY TO EXPEDITE GROWTH 269 11.3 CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS 273 11.3.1 SHIFT TOWARD CUSTOM AND MODIFIED PEPTIDES TO DRIVE MARKET 273 11.4 ACADEMIC & RESEARCH INSTITUTES 276 11.4.1 INCREASING FINANCIAL AND REGULATORY SUPPORT FOR RESEARCH TO SUPPORT GROWTH 276 11.5 MEDICAL DEVICE COMPANIES 280 11.5.1 BOOMING PEPTIDE-BASED DRUG DELIVERIES TO PROMOTE GROWTH 280 11.6 HOSPITALS & DIAGNOSTIC CENTERS 283 11.6.1 RISING DEMAND FOR PEPTIDE-BASED DIAGNOSTICS TO FAVOR GROWTH 283   12 PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER 287 12.1 INTRODUCTION 288 12.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES 288 12.2.1 INCREASING FOCUS ON PEPTIDE-BASED THERAPEUTICS IN ONCOLOGY AND METABOLIC DISORDERS TO INTENSIFY GROWTH 288 12.3 MEDICAL DEVICE COMPANIES 292 12.3.1 NEED TO DETECT INFECTIOUS DISEASES, CANCER, AND METABOLIC DISORDERS TO AID GROWTH 292 12.4 HOSPITALS & DIAGNOSTIC CENTERS 295 12.4.1 RISING USE OF PEPTIDE BIOMARKERS TO SUPPORT GROWTH 295 12.5 ACADEMIC & RESEARCH INSTITUTES 299 12.5.1 GROWING FOCUS ON DRUG DESIGN, VACCINE DEVELOPMENT, AND CANCER RESEARCH TO BOOST MARKET 299 12.6 CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS 302 12.6.1 INCREASING DEMAND FOR COST-EFFECTIVE PEPTIDE SYNTHESIS SERVICES TO FACILITATE GROWTH 302 13 PEPTIDE SYNTHESIS MARKET, BY REGION 306 13.1 INTRODUCTION 307 13.2 NORTH AMERICA 307 13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 308 13.2.2 US 314 13.2.2.1 Well-developed healthcare and research infrastructure to aid growth 314 13.2.3 CANADA 320 13.2.3.1 Increasing government funding for advanced drugs to amplify growth 320 13.3 EUROPE 326 13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 327 13.3.2 GERMANY 333 13.3.2.1 Germany to hold largest market share in Europe 333 13.3.3 UK 339 13.3.3.1 Increasing peptide synthesis research to contribute to growth 339 13.3.4 FRANCE 345 13.3.4.1 Favorable government initiatives to augment growth 345 13.3.5 ITALY 351 13.3.5.1 Growing public and private sector investments to propel market 351 13.3.6 SPAIN 357 13.3.6.1 Rising focus on advanced therapies to expedite growth 357 13.3.7 REST OF EUROPE 363   13.4 ASIA PACIFIC 369 13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 370 13.4.2 CHINA 377 13.4.2.1 Expanding biopharma sector to advance growth 377 13.4.3 JAPAN 384 13.4.3.1 Growing geriatric population to fuel market 384 13.4.4 INDIA 390 13.4.4.1 Increasing investments and developments in biotechnology to favor growth 390 13.4.5 SOUTH KOREA 395 13.4.5.1 Booming biotechnology sector to amplify growth 395 13.4.6 AUSTRALIA 402 13.4.6.1 Increasing government funding and initiatives to augment growth 402 13.4.7 REST OF ASIA PACIFIC 407 13.5 LATIN AMERICA 413 13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 414 13.5.2 BRAZIL 420 13.5.2.1 Growing interest in peptide-based drugs to fuel market 420 13.5.3 MEXICO 426 13.5.3.1 Increasing initiatives for stem cell research and regenerative medicine projects to foster growth 426 13.5.4 REST OF LATIN AMERICA 432 13.6 MIDDLE EAST 438 13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST 438 13.6.2 GCC COUNTRIES 445 13.6.2.1 Saudi Arabia 450 13.6.2.1.1 Increasing government-backed investments for infrastructure to aid growth 450 13.6.2.2 UAE 456 13.6.2.2.1 High prevalence of diabetes and cardiovascular diseases to augment growth 456 13.6.2.3 Rest of GCC Countries 462 13.6.3 REST OF MIDDLE EAST 469 13.7 AFRICA 475 13.7.1 INCREASING INVESTMENTS IN PHARMACEUTICAL INFRASTRUCTURE AND LIFE SCIENCE INNOVATIONS TO BOOST MARKET 475 13.7.2 MACROECONOMIC OUTLOOK FOR AFRICA 475   14 COMPETITIVE LANDSCAPE 482 14.1 OVERVIEW 482 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2025 482 14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PEPTIDE SYNTHESIS MARKET 483 14.3 REVENUE ANALYSIS, 2019–2023 484 14.4 MARKET SHARE ANALYSIS, 2023 485 14.5 COMPANY VALUATION AND FINANCIAL METRICS 487 14.5.1 COMPANY VALUATION 487 14.5.2 FINANCIAL METRICS 487 14.6 BRAND/PRODUCT COMPARISON 488 14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 489 14.7.1 STARS 489 14.7.2 EMERGING LEADERS 489 14.7.3 PERVASIVE PLAYERS 489 14.7.4 PARTICIPANTS 489 14.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 491 14.7.5.1 Company footprint 491 14.7.5.2 Region footprint 492 14.7.5.3 Offering footprint 493 14.7.5.4 Technique footprint 494 14.7.5.5 Application footprint 495 14.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 496 14.8.1 PROGRESSIVE COMPANIES 496 14.8.2 RESPONSIVE COMPANIES 496 14.8.3 DYNAMIC COMPANIES 496 14.8.4 STARTING BLOCKS 496 14.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 498 14.8.5.1 Detailed list of key startups/SMEs 498 14.8.5.2 Competitive benchmarking of startups/SMEs 499 14.9 COMPETITIVE SCENARIO 500 14.9.1 PRODUCT LAUNCHES 500 14.9.2 DEALS 501 14.9.3 EXPANSIONS 502   15 COMPANY PROFILES 503 15.1 KEY PLAYERS 503 15.1.1 THERMO FISHER SCIENTIFIC INC. 503 15.1.1.1 Business overview 503 15.1.1.2 Products/Services offered 505 15.1.1.3 Recent developments 506 15.1.1.3.1 Product launches 506 15.1.1.4 MnM view 506 15.1.1.4.1 Key strengths 506 15.1.1.4.2 Strategic choices 506 15.1.1.4.3 Weaknesses and competitive threats 506 15.1.2 MERCK KGAA 507 15.1.2.1 Business overview 507 15.1.2.2 Products/Services offered 508 15.1.2.3 MnM view 511 15.1.2.3.1 Key strengths 511 15.1.2.3.2 Strategic choices 511 15.1.2.3.3 Weaknesses and competitive threats 511 15.1.3 AGILENT TECHNOLOGIES, INC. 512 15.1.3.1 Business overview 512 15.1.3.2 Products/Services offered 513 15.1.3.3 MnM view 514 15.1.3.3.1 Key strengths 514 15.1.3.3.2 Strategic choices 514 15.1.3.3.3 Weaknesses and competitive threats 514 15.1.4 GENSCRIPT 515 15.1.4.1 Business overview 515 15.1.4.2 Products/Services offered 516 15.1.4.3 Recent developments 517 15.1.4.3.1 Expansions 517 15.1.4.4 MnM view 517 15.1.4.4.1 Key strengths 517 15.1.4.4.2 Strategic choices 517 15.1.4.4.3 Weaknesses and competitive threats 518 15.1.5 KANEKA CORPORATION 519 15.1.5.1 Business overview 519 15.1.5.2 Products/Services offered 520 15.1.5.3 Recent developments 521 15.1.5.3.1 Expansions 521   15.1.5.4 MnM view 521 15.1.5.4.1 Key strengths 521 15.1.5.4.2 Strategic choices 521 15.1.5.4.3 Weaknesses and competitive threats 521 15.1.6 BACHEM 522 15.1.6.1 Business overview 522 15.1.6.2 Products/Services offered 523 15.1.6.3 Recent developments 524 15.1.6.3.1 Deals 524 15.1.7 SYNGENE INTERNATIONAL LIMITED 525 15.1.7.1 Business overview 525 15.1.7.2 Products/Services offered 526 15.1.8 MESA LABS, INC. 527 15.1.8.1 Business overview 527 15.1.8.2 Products/Services offered 528 15.1.8.3 Recent developments 529 15.1.8.3.1 Product launches 529 15.1.8.3.2 Deals 529 15.1.9 BIOTAGE 530 15.1.9.1 Business overview 530 15.1.9.2 Products/Services offered 532 15.1.10 CEM CORPORATION 533 15.1.10.1 Business overview 533 15.1.10.2 Products/Services offered 533 15.1.10.3 Recent developments 534 15.1.10.3.1 Product launches 534 15.1.10.3.2 Deals 534 15.1.11 DALTON PHARMA SERVICES 535 15.1.11.1 Business overview 535 15.1.11.2 Products/Services offered 535 15.1.12 BIO-SYNTHESIS INC. 536 15.1.12.1 Business overview 536 15.1.12.2 Products/Services offered 537 15.1.13 CSBIO 538 15.1.13.1 Business overview 538 15.1.13.2 Products/Services offered 538 15.1.14 PROTEOGENIX 539 15.1.14.1 Business overview 539 15.1.14.2 Products/Services offered 539   15.1.15 INNOVAGEN AB 540 15.1.15.1 Business overview 540 15.1.15.2 Products/Services offered 540 15.1.16 BIOSYNTH 541 15.1.16.1 Business overview 541 15.1.16.2 Products/Services offered 541 15.1.16.2.1 Deals 542 15.2 OTHER PLAYERS 543 15.2.1 AURIGENE PHARMACEUTICAL SERVICES LTD. 543 15.2.2 CORDENPHARMA 544 15.2.3 JPT PEPTIDE TECHNOLOGIES 545 15.2.4 PUROLITE 546 15.2.5 BIOMATIK 547 15.2.6 CPC SCIENTIFIC INC. 548 15.2.7 ADVANCED CHEMTECH, INC. 549 15.2.8 AMBIOPHARM INC. 550 15.2.9 LUXEMBOURG BIO TECHNOLOGIES 551 15.2.10 AAPPTEC 552 15.2.11 ANYGEN 553 15.2.12 CHEMPEP 554 15.2.13 PROTEOGENIX 555 16 APPENDIX 556 16.1 DISCUSSION GUIDE 556 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 560 16.3 CUSTOMIZATION OPTIONS 562 16.4 RELATED REPORTS 562 16.5 AUTHOR DETAILS 563
圖表清單 List of Tables & Figures
TABLE 1 PEPTIDE SYNTHESIS MARKET: INCLUSIONS AND EXCLUSIONS 56 TABLE 2 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 68 TABLE 3 PEPTIDE SYNTHESIS MARKET: RISK ANALYSIS 71 TABLE 4 PEPTIDE SYNTHESIS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 82 TABLE 5 AVERAGE SELLING PRICE TREND OF PEPTIDE SYNTHESIS PRODUCTS, BY KEY PLAYER, 2022–2024 88 TABLE 6 AVERAGE SELLING PRICE TREND OF PEPTIDE SYNTHESIS PRODUCTS, BY REGION, 2022–2024 91 TABLE 7 PEPTIDE SYNTHESIS MARKET: PRODUCT MANUFACTURERS 97 TABLE 8 PEPTIDE SYNTHESIS MARKET: SERVICE PROVIDERS 98 TABLE 9 PEPTIDE SYNTHESIS MARKET: END USERS 98 TABLE 10 PEPTIDE SYNTHESIS MARKET: REGULATORY BODIES 99 TABLE 11 PEPTIDE SYNTHESIS MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2024 104 TABLE 12 IMPORT VALUE FOR HS CODE 902720 (CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS), 2019–2023 (USD) 105 TABLE 13 EXPORT VALUE FOR HS CODE 902720 (CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS), 2019–2023 (USD) 106 TABLE 14 IMPORT VALUE FOR HS CODE 841933 (LYOPHILISATION APPARATUS, FREEZE DRYING UNITS, AND SPRAY DRYERS), 2022–2023 (USD) 106 TABLE 15 EXPORT VALUE FOR HS CODE 841933 (LYOPHILISATION APPARATUS, FREEZE DRYING UNITS, AND SPRAY DRYERS), 2022–2023 (USD) 107 TABLE 16 PEPTIDE SYNTHESIS MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 107 TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 109 TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 109 TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 110 TABLE 20 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111 TABLE 21 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 111 TABLE 22 PEPTIDE SYNTHESIS MARKET: PORTER’S FIVE FORCES ANALYSIS 114 TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PEPTIDE SYNTHESIS PRODUCTS 117 TABLE 24 KEY BUYING CRITERIA FOR PEPTIDE SYNTHESIS PRODUCTS, BY END USER 118 TABLE 25 PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 123 TABLE 26 PEPTIDE SYNTHESIS PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION) 124 TABLE 27 NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 124 TABLE 28 EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 125 TABLE 29 ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 125 TABLE 30 LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 126 TABLE 31 MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION) 126 TABLE 32 GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 126 TABLE 33 PEPTIDE SYNTHESIS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 127 TABLE 34 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 127 TABLE 35 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 128 TABLE 36 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 128 TABLE 37 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 129 TABLE 38 MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 129 TABLE 39 GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 129 TABLE 40 PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 131 TABLE 41 PEPTIDE CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 131 TABLE 42 PEPTIDE CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION) 132 TABLE 43 NORTH AMERICA: PEPTIDE CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 132 TABLE 44 EUROPE: PEPTIDE CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 133 TABLE 45 ASIA PACIFIC: PEPTIDE CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 133 TABLE 46 LATIN AMERICA: PEPTIDE CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 134 TABLE 47 MIDDLE EAST: PEPTIDE CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION) 134 TABLE 48 GCC COUNTRIES: PEPTIDE CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 134 TABLE 49 REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 135 TABLE 50 REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 136 TABLE 51 NORTH AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 136 TABLE 52 EUROPE: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 136 TABLE 53 ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 137 TABLE 54 LATIN AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 137 TABLE 55 MIDDLE EAST: REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 137 TABLE 56 GCC COUNTRIES: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 138 TABLE 57 RESINS MARKET, BY REGION, 2022–2029 (USD MILLION) 138 TABLE 58 NORTH AMERICA: RESINS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 139 TABLE 59 EUROPE: RESINS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 139 TABLE 60 ASIA PACIFIC: RESINS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 139 TABLE 61 LATIN AMERICA: RESINS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 140 TABLE 62 MIDDLE EAST: RESINS MARKET, BY REGION, 2022–2029 (USD MILLION) 140 TABLE 63 GCC COUNTRIES: RESINS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 140 TABLE 64 AMINO ACIDS MARKET, BY REGION, 2022–2029 (USD MILLION) 141 TABLE 65 NORTH AMERICA: AMINO ACIDS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 142 TABLE 66 EUROPE: AMINO ACIDS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 142 TABLE 67 ASIA PACIFIC: AMINO ACIDS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 142 TABLE 68 LATIN AMERICA: AMINO ACIDS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 143 TABLE 69 MIDDLE EAST: AMINO ACIDS MARKET, BY REGION, 2022–2029 (USD MILLION) 143 TABLE 70 GCC COUNTRIES: AMINO ACIDS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 143 TABLE 71 COUPLING REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 144 TABLE 72 NORTH AMERICA: COUPLING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 145 TABLE 73 EUROPE: COUPLING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 145 TABLE 74 ASIA PACIFIC: COUPLING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 145 TABLE 75 LATIN AMERICA: COUPLING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 146 TABLE 76 MIDDLE EAST: COUPLING REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 146 TABLE 77 GCC COUNTRIES: COUPLING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 146 TABLE 78 DYES & FLUORESCENT LABELING REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 147 TABLE 79 NORTH AMERICA: DYES & FLUORESCENT LABELING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 148 TABLE 80 EUROPE: DYES & FLUORESCENT LABELING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 148 TABLE 81 ASIA PACIFIC: DYES & FLUORESCENT LABELING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 149 TABLE 82 LATIN AMERICA: DYES & FLUORESCENT LABELING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 149 TABLE 83 MIDDLE EAST: DYES & FLUORESCENT LABELING REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 149 TABLE 84 GCC COUNTRIES: DYES & FLUORESCENT LABELING REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 150 TABLE 85 DEPROTECTION REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 151 TABLE 86 NORTH AMERICA: DEPROTECTION REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 151 TABLE 87 EUROPE: DEPROTECTION REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 151 TABLE 88 ASIA PACIFIC: DEPROTECTION REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 152 TABLE 89 LATIN AMERICA: DEPROTECTION REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 152 TABLE 90 MIDDLE EAST: DEPROTECTION REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 152 TABLE 91 GCC COUNTRIES: DEPROTECTION REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 153 TABLE 92 CLEAVAGE REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 153 TABLE 93 NORTH AMERICA: CLEAVAGE REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 154 TABLE 94 EUROPE: CLEAVAGE REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 154 TABLE 95 ASIA PACIFIC: CLEAVAGE REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 154 TABLE 96 LATIN AMERICA: CLEAVAGE REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 155 TABLE 97 MIDDLE EAST: CLEAVAGE REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 155 TABLE 98 GCC COUNTRIES: CLEAVAGE REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 155 TABLE 99 OTHER PEPTIDE SYNTHESIS REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 156 TABLE 100 NORTH AMERICA: OTHER PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 156 TABLE 101 EUROPE: OTHER PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 157 TABLE 102 ASIA PACIFIC: OTHER PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 157 TABLE 103 LATIN AMERICA: OTHER PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 158 TABLE 104 MIDDLE EAST: OTHER PEPTIDE SYNTHESIS REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 158 TABLE 105 GCC COUNTRIES: OTHER PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 158 TABLE 106 OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION) 159 TABLE 107 NORTH AMERICA: OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET, 2022–2029 (USD MILLION) 160 TABLE 108 EUROPE: OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 160 TABLE 109 ASIA PACIFIC: OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 161 TABLE 110 LATIN AMERICA: OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 161 TABLE 111 MIDDLE EAST: OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION) 161 TABLE 112 GCC COUNTRIES: OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 162 TABLE 113 PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 162 TABLE 114 PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 163 TABLE 115 NORTH AMERICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 163 TABLE 116 EUROPE: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 163 TABLE 117 ASIA PACIFIC: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 164 TABLE 118 LATIN AMERICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 164 TABLE 119 MIDDLE EAST: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 164 TABLE 120 GCC COUNTRIES: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 165 TABLE 121 PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 166 TABLE 122 PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 166 TABLE 123 NORTH AMERICA: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 166 TABLE 124 EUROPE: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 167 TABLE 125 ASIA PACIFIC: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 167 TABLE 126 LATIN AMERICA: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 168 TABLE 127 MIDDLE EAST: PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 168 TABLE 128 GCC COUNTRIES: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 168 TABLE 129 AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 169 TABLE 130 NORTH AMERICA: AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 170 TABLE 131 EUROPE: AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 170 TABLE 132 ASIA PACIFIC: AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 171 TABLE 133 LATIN AMERICA: AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 171 TABLE 134 MIDDLE EAST: AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 171 TABLE 135 GCC COUNTRIES: AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 172 TABLE 136 MANUAL PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 172 TABLE 137 NORTH AMERICA: MANUAL PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 173 TABLE 138 EUROPE: MANUAL PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 173 TABLE 139 ASIA PACIFIC: MANUAL PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 174 TABLE 140 LATIN AMERICA: MANUAL PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 174 TABLE 141 MIDDLE EAST: MANUAL PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 174 TABLE 142 GCC COUNTRIES: MANUAL PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 175 TABLE 143 CHROMATOGRAPHY SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 176 TABLE 144 NORTH AMERICA: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 176 TABLE 145 EUROPE: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 176 TABLE 146 ASIA PACIFIC: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 177 TABLE 147 LATIN AMERICA: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 177 TABLE 148 MIDDLE EAST: CHROMATOGRAPHY SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 177 TABLE 149 GCC COUNTRIES: CHROMATOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 178 TABLE 150 LYOPHILIZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 179 TABLE 151 NORTH AMERICA: LYOPHILIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 179 TABLE 152 EUROPE: LYOPHILIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 179 TABLE 153 ASIA PACIFIC: LYOPHILIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 180 TABLE 154 LATIN AMERICA: LYOPHILIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 180 TABLE 155 MIDDLE EAST: LYOPHILIZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 180 TABLE 156 GCC COUNTRIES: LYOPHILIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 181 TABLE 157 OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 181 TABLE 158 NORTH AMERICA: OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 182 TABLE 159 EUROPE: OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 182 TABLE 160 ASIA PACIFIC: OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 183 TABLE 161 LATIN AMERICA: OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 183 TABLE 162 MIDDLE EAST: OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 183 TABLE 163 GCC COUNTRIES: OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 184 TABLE 164 PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 186 TABLE 165 PEPTIDE SYNTHESIS SERVICE MARKET, BY REGION, 2022–2029 (USD MILLION) 187 TABLE 166 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 187 TABLE 167 EUROPE: PEPTIDE SYNTHESIS SERVICE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 188 TABLE 168 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 188 TABLE 169 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 189 TABLE 170 MIDDLE EAST: PEPTIDE SYNTHESIS SERVICE MARKET, BY REGION, 2022–2029 (USD MILLION) 189 TABLE 171 GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 189 TABLE 172 PEPTIDE PURIFICATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 190 TABLE 173 NORTH AMERICA: PEPTIDE PURIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 191 TABLE 174 EUROPE: PEPTIDE PURIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 191 TABLE 175 ASIA PACIFIC: PEPTIDE PURIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 192 TABLE 176 LATIN AMERICA: PEPTIDE PURIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 192 TABLE 177 MIDDLE EAST: PEPTIDE PURIFICATION SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 192 TABLE 178 GCC COUNTRIES: PEPTIDE PURIFICATION SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 193 TABLE 179 PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 193 TABLE 180 NORTH AMERICA: PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 194 TABLE 181 EUROPE: PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 194 TABLE 182 ASIA PACIFIC: PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 195 TABLE 183 LATIN AMERICA: PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 195 TABLE 184 MIDDLE EAST: PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 195 TABLE 185 GCC COUNTRIES: PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 196 TABLE 186 PEPTIDE ANALYSIS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 197 TABLE 187 NORTH AMERICA: PEPTIDE ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 197 TABLE 188 EUROPE: PEPTIDE ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 197 TABLE 189 ASIA PACIFIC: PEPTIDE ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 198 TABLE 190 LATIN AMERICA: PEPTIDE ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 198 TABLE 191 MIDDLE EAST: PEPTIDE ANALYSIS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION) 199 TABLE 192 GCC COUNTRIES: PEPTIDE ANALYSIS SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 199 TABLE 193 PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 201 TABLE 194 PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 201 TABLE 195 PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY REGION, 2022–2029 (USD MILLION) 202 TABLE 196 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION) 202 TABLE 197 EUROPE: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION) 203 TABLE 198 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION) 203 TABLE 199 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION) 204 TABLE 200 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY REGION, 2022–2029 (USD MILLION) 204 TABLE 201 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION) 204 TABLE 202 SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION, 2022–2029 (USD MILLION) 205 TABLE 203 NORTH AMERICA: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 206 TABLE 204 EUROPE: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 206 TABLE 205 ASIA PACIFIC: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 207 TABLE 206 LATIN AMERICA: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 207 TABLE 207 MIDDLE EAST: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION, 2022–2029 (USD MILLION) 207 TABLE 208 GCC COUNTRIES: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 208 TABLE 209 LIQUID-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION, 2022–2029 (USD MILLION) 209 TABLE 210 NORTH AMERICA: LIQUID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 209 TABLE 211 EUROPE: LIQUID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 209 TABLE 212 ASIA PACIFIC: LIQUID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 210 TABLE 213 LATIN AMERICA: LIQUID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 210 TABLE 214 MIDDLE EAST: LIQUID-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION, 2022–2029 (USD MILLION) 210 TABLE 215 GCC COUNTRIES: LIQUID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 211 TABLE 216 PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY REGION, 2022–2029 (USD MILLION) 212 TABLE 217 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION) 212 TABLE 218 EUROPE: PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION) 213 TABLE 219 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION) 213 TABLE 220 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION) 214 TABLE 221 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY REGION, 2022–2029 (USD MILLION) 214 TABLE 222 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION) 214 TABLE 223 PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 215 TABLE 224 PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY REGION, 2022–2029 (USD MILLION) 215 TABLE 225 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION) 216 TABLE 226 EUROPE: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION) 216 TABLE 227 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION) 217 TABLE 228 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION) 217 TABLE 229 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY REGION, 2022–2029 (USD MILLION) 217 TABLE 230 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION) 218 TABLE 231 PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION) 219 TABLE 232 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 219 TABLE 233 EUROPE: PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 220 TABLE 234 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 220 TABLE 235 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 221 TABLE 236 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION) 221 TABLE 237 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION) 221 TABLE 238 PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS, BY REGION, 2022–2029 (USD MILLION) 222 TABLE 239 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION) 222 TABLE 240 EUROPE: PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION) 223 TABLE 241 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION) 223 TABLE 242 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION) 224 TABLE 243 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS, BY REGION, 2022–2029 (USD MILLION) 224 TABLE 244 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS, BY COUNTRY, 2022–2029 (USD MILLION) 224 TABLE 245 PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 226 TABLE 246 PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 227 TABLE 247 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 227 TABLE 248 EUROPE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 228 TABLE 249 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 228 TABLE 250 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 229 TABLE 251 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 229 TABLE 252 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 229 TABLE 253 PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 230 TABLE 254 PEPTIDE SYNTHESIS MARKET FOR CANCER, BY REGION, 2022–2029 (USD MILLION) 231 TABLE 255 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR CANCER, BY COUNTRY, 2022–2029 (USD MILLION) 231 TABLE 256 EUROPE: PEPTIDE SYNTHESIS MARKET FOR CANCER, BY COUNTRY, 2022–2029 (USD MILLION) 231 TABLE 257 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CANCER, BY COUNTRY, 2022–2029 (USD MILLION) 232 TABLE 258 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CANCER, BY COUNTRY, 2022–2029 (USD MILLION) 232 TABLE 259 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR CANCER, BY REGION, 2022–2029 (USD MILLION) 232 TABLE 260 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR CANCER, BY COUNTRY, 2022–2029 (USD MILLION) 233 TABLE 261 PEPTIDE SYNTHESIS MARKET FOR DIABETES, BY REGION, 2022–2029 (USD MILLION) 234 TABLE 262 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION) 234 TABLE 263 EUROPE: PEPTIDE SYNTHESIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION) 234 TABLE 264 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION) 235 TABLE 265 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION) 235 TABLE 266 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR DIABETES, BY REGION, 2022–2029 (USD MILLION) 235 TABLE 267 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR DIABETES, BY COUNTRY, 2022–2029 (USD MILLION) 236 TABLE 268 PEPTIDE SYNTHESIS MARKET FOR OBESITY, BY REGION, 2022–2029 (USD MILLION) 237 TABLE 269 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR OBESITY, BY COUNTRY, 2022–2029 (USD MILLION) 237 TABLE 270 EUROPE: PEPTIDE SYNTHESIS MARKET FOR OBESITY, BY COUNTRY, 2022–2029 (USD MILLION) 237 TABLE 271 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR OBESITY, BY COUNTRY, 2022–2029 (USD MILLION) 238 TABLE 272 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR OBESITY, BY COUNTRY, 2022–2029 (USD MILLION) 238 TABLE 273 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR OBESITY, BY REGION, 2022–2029 (USD MILLION) 238 TABLE 274 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR OBESITY, BY COUNTRY, 2022–2029 (USD MILLION) 239 TABLE 275 PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES, BY REGION, 2022–2029 (USD MILLION) 240 TABLE 276 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 240 TABLE 277 EUROPE: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 241 TABLE 278 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 241 TABLE 279 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 242 TABLE 280 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES, BY REGION, 2022–2029 (USD MILLION) 242 TABLE 281 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 242 TABLE 282 PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES, BY REGION, 2022–2029 (USD MILLION) 243 TABLE 283 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 244 TABLE 284 EUROPE: PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 244 TABLE 285 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 245 TABLE 286 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 245 TABLE 287 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES, BY REGION, 2022–2029 (USD MILLION) 245 TABLE 288 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION) 246 TABLE 289 PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 246 TABLE 290 PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY REGION, 2022–2029 (USD MILLION) 247 TABLE 291 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY COUNTRY, 2022–2029 (USD MILLION) 247 TABLE 292 EUROPE: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY COUNTRY, 2022–2029 (USD MILLION) 248 TABLE 293 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY COUNTRY, 2022–2029 (USD MILLION) 248 TABLE 294 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY COUNTRY, 2022–2029 (USD MILLION) 249 TABLE 295 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY REGION, 2022–2029 (USD MILLION) 249 TABLE 296 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY COUNTRY, 2022–2029 (USD MILLION) 249 TABLE 297 PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY REGION, 2022–2029 (USD MILLION) 250 TABLE 298 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION) 251 TABLE 299 EUROPE: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION) 251 TABLE 300 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION) 252 TABLE 301 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION) 252 TABLE 302 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY REGION, 2022–2029 (USD MILLION) 252 TABLE 303 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION) 253 TABLE 304 PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY REGION, 2022–2029 (USD MILLION) 254 TABLE 305 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY COUNTRY, 2022–2029 (USD MILLION) 254 TABLE 306 EUROPE: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY COUNTRY, 2022–2029 (USD MILLION) 255 TABLE 307 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY COUNTRY, 2022–2029 (USD MILLION) 255 TABLE 308 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY COUNTRY, 2022–2029 (USD MILLION) 256 TABLE 309 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY REGION, 2022–2029 (USD MILLION) 256 TABLE 310 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS, BY COUNTRY, 2022–2029 (USD MILLION) 256 TABLE 311 PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES, BY REGION, 2022–2029 (USD MILLION) 257 TABLE 312 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2022–2029 (USD MILLION) 258 TABLE 313 EUROPE: PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2022–2029 (USD MILLION) 258 TABLE 314 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2022–2029 (USD MILLION) 259 TABLE 315 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2022–2029 (USD MILLION) 259 TABLE 316 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES, BY REGION, 2022–2029 (USD MILLION) 259 TABLE 317 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES, BY COUNTRY, 2022–2029 (USD MILLION) 260 TABLE 318 PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 261 TABLE 319 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 261 TABLE 320 EUROPE: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 262 TABLE 321 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 262 TABLE 322 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 263 TABLE 323 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 263 TABLE 324 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 263 TABLE 325 PEPTIDE SYNTHESIS MARKET FOR DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 264 TABLE 326 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 265 TABLE 327 EUROPE: PEPTIDE SYNTHESIS MARKET FOR DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 265 TABLE 328 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 266 TABLE 329 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 266 TABLE 330 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 266 TABLE 331 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 267 TABLE 332 PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 269 TABLE 333 PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2022–2029 (USD MILLION) 270 TABLE 334 NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 270 TABLE 335 EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 271 TABLE 336 ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 271 TABLE 337 LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 272 TABLE 338 MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2022–2029 (USD MILLION) 272 TABLE 339 GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 272 TABLE 340 PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS, BY REGION, 2022–2029 (USD MILLION) 273 TABLE 341 NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION) 274 TABLE 342 EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION) 274 TABLE 343 ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION) 275 TABLE 344 LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION) 275 TABLE 345 MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS, BY REGION, 2022–2029 (USD MILLION) 275 TABLE 346 GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION) 276 TABLE 347 PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 277 TABLE 348 NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 277 TABLE 349 EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 278 TABLE 350 ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 278 TABLE 351 LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 279 TABLE 352 MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 279 TABLE 353 GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 279 TABLE 354 PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2022–2029 (USD MILLION) 280 TABLE 355 NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 281 TABLE 356 EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 281 TABLE 357 ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 282 TABLE 358 LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 282 TABLE 359 MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2022–2029 (USD MILLION) 282 TABLE 360 GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 283 TABLE 361 PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2022–2029 (USD MILLION) 284 TABLE 362 NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 284 TABLE 363 EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 285 TABLE 364 ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 285 TABLE 365 LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 286 TABLE 366 MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2022–2029 (USD MILLION) 286 TABLE 367 GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 286 TABLE 368 PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 288 TABLE 369 PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2022–2029 (USD MILLION) 289 TABLE 370 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 289 TABLE 371 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 290 TABLE 372 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 290 TABLE 373 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 291 TABLE 374 MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2022–2029 (USD MILLION) 291 TABLE 375 GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 291 TABLE 376 PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2022–2029 (USD MILLION) 292 TABLE 377 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 293 TABLE 378 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 293 TABLE 379 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 294 TABLE 380 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 294 TABLE 381 MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2022–2029 (USD MILLION) 294 TABLE 382 GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 295 TABLE 383 PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2022–2029 (USD MILLION) 296 TABLE 384 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 296 TABLE 385 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 297 TABLE 386 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 297 TABLE 387 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 298 TABLE 388 MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2022–2029 (USD MILLION) 298 TABLE 389 GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 298 TABLE 390 PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 299 TABLE 391 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 300 TABLE 392 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 300 TABLE 393 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 301 TABLE 394 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 301 TABLE 395 MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 301 TABLE 396 GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 302 TABLE 397 PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS, BY REGION, 2022–2029 (USD MILLION) 303 TABLE 398 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION) 303 TABLE 399 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION) 304 TABLE 400 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION) 304 TABLE 401 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION) 305 TABLE 402 MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS, BY REGION, 2022–2029 (USD MILLION) 305 TABLE 403 GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION) 305 TABLE 404 PEPTIDE SYNTHESIS MARKET, BY REGION, 2022–2029 (USD MILLION) 307 TABLE 405 KEY MACROECONOMIC INDICATORS FOR NORTH AMERICA 308 TABLE 406 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 309 TABLE 407 NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 310 TABLE 408 NORTH AMERICA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 310 TABLE 409 NORTH AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 310 TABLE 410 NORTH AMERICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 311 TABLE 411 NORTH AMERICA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 311 TABLE 412 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 311 TABLE 413 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 312 TABLE 414 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 312 TABLE 415 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 312 TABLE 416 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 313 TABLE 417 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 313 TABLE 418 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 313 TABLE 419 NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 314 TABLE 420 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 314 TABLE 421 US: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 315 TABLE 422 US: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 315 TABLE 423 US: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 316 TABLE 424 US: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 316 TABLE 425 US: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 316 TABLE 426 US: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 317 TABLE 427 US: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 317 TABLE 428 US: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 317 TABLE 429 US: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 318 TABLE 430 US: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 318 TABLE 431 US: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 318 TABLE 432 US: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 319 TABLE 433 US: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 319 TABLE 434 US: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 320 TABLE 435 US: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 320 TABLE 436 CANADA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 321 TABLE 437 CANADA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 321 TABLE 438 CANADA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 322 TABLE 439 CANADA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 322 TABLE 440 CANADA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 322 TABLE 441 CANADA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 323 TABLE 442 CANADA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 323 TABLE 443 CANADA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 323 TABLE 444 CANADA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 324 TABLE 445 CANADA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 324 TABLE 446 CANADA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 324 TABLE 447 CANADA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 325 TABLE 448 CANADA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 325 TABLE 449 CANADA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 326 TABLE 450 CANADA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 326 TABLE 451 KEY MACROECONOMIC INDICATORS FOR EUROPE 327 TABLE 452 EUROPE: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 328 TABLE 453 EUROPE: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 328 TABLE 454 EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 328 TABLE 455 EUROPE: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 329 TABLE 456 EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 329 TABLE 457 EUROPE: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 329 TABLE 458 EUROPE: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 330 TABLE 459 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 330 TABLE 460 EUROPE: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 330 TABLE 461 EUROPE: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 331 TABLE 462 EUROPE: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 331 TABLE 463 EUROPE: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 331 TABLE 464 EUROPE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 332 TABLE 465 EUROPE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 332 TABLE 466 EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 333 TABLE 467 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 333 TABLE 468 GERMANY: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 334 TABLE 469 GERMANY: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 335 TABLE 470 GERMANY: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 335 TABLE 471 GERMANY: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 335 TABLE 472 GERMANY: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 336 TABLE 473 GERMANY: PEPTIDE SYNTHESIS SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 336 TABLE 474 GERMANY: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 336 TABLE 475 GERMANY: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 337 TABLE 476 GERMANY: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 337 TABLE 477 GERMANY: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 337 TABLE 478 GERMANY: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 338 TABLE 479 GERMANY: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 338 TABLE 480 GERMANY: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 338 TABLE 481 GERMANY: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 339 TABLE 482 GERMANY: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 339 TABLE 483 UK: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 340 TABLE 484 UK: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 340 TABLE 485 UK: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 341 TABLE 486 UK: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 341 TABLE 487 UK: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 341 TABLE 488 UK: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 342 TABLE 489 UK: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 342 TABLE 490 UK: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 342 TABLE 491 UK: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 343 TABLE 492 UK: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 343 TABLE 493 UK: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 343 TABLE 494 UK: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 344 TABLE 495 UK: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 344 TABLE 496 UK: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 345 TABLE 497 UK: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 345 TABLE 498 FRANCE: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 346 TABLE 499 FRANCE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 346 TABLE 500 FRANCE: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 347 TABLE 501 FRANCE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 347 TABLE 502 FRANCE: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 347 TABLE 503 FRANCE: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 348 TABLE 504 FRANCE: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 348 TABLE 505 FRANCE: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 348 TABLE 506 FRANCE: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 349 TABLE 507 FRANCE: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 349 TABLE 508 FRANCE: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 349 TABLE 509 FRANCE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 350 TABLE 510 FRANCE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 350 TABLE 511 FRANCE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 351 TABLE 512 FRANCE: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 351 TABLE 513 ITALY: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 352 TABLE 514 ITALY: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 352 TABLE 515 ITALY: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 353 TABLE 516 ITALY: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 353 TABLE 517 ITALY: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 353 TABLE 518 ITALY: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 354 TABLE 519 ITALY: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 354 TABLE 520 ITALY: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 354 TABLE 521 ITALY: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 355 TABLE 522 ITALY: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 355 TABLE 523 ITALY: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 355 TABLE 524 ITALY: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 356 TABLE 525 ITALY: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 356 TABLE 526 ITALY: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 357 TABLE 527 ITALY: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 357 TABLE 528 SPAIN: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 358 TABLE 529 SPAIN: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 358 TABLE 530 SPAIN: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 358 TABLE 531 SPAIN: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 359 TABLE 532 SPAIN: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 359 TABLE 533 SPAIN: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 359 TABLE 534 SPAIN: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 360 TABLE 535 SPAIN: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 360 TABLE 536 SPAIN: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 360 TABLE 537 SPAIN: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 361 TABLE 538 SPAIN: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 361 TABLE 539 SPAIN: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 361 TABLE 540 SPAIN: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 362 TABLE 541 SPAIN: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 362 TABLE 542 SPAIN: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 363 TABLE 543 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 364 TABLE 544 REST OF EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 364 TABLE 545 REST OF EUROPE: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 364 TABLE 546 REST OF EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 365 TABLE 547 REST OF EUROPE: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 365 TABLE 548 REST OF EUROPE: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 365 TABLE 549 REST OF EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 366 TABLE 550 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 366 TABLE 551 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 366 TABLE 552 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 367 TABLE 553 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 367 TABLE 554 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 367 TABLE 555 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 368 TABLE 556 REST OF EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 368 TABLE 557 REST OF EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 369 TABLE 558 KEY MACROECONOMIC INDICATORS FOR ASIA PACIFIC 370 TABLE 559 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 372 TABLE 560 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 372 TABLE 561 ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 372 TABLE 562 ASIA PACIFIC: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 373 TABLE 563 ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 373 TABLE 564 ASIA PACIFIC: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 373 TABLE 565 ASIA PACIFIC: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 374 TABLE 566 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 374 TABLE 567 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 374 TABLE 568 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 375 TABLE 569 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 375 TABLE 570 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 375 TABLE 571 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 376 TABLE 572 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 376 TABLE 573 ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 377 TABLE 574 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 377 TABLE 575 CHINA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 378 TABLE 576 CHINA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 378 TABLE 577 CHINA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 379 TABLE 578 CHINA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 379 TABLE 579 CHINA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 379 TABLE 580 CHINA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 380 TABLE 581 CHINA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 380 TABLE 582 CHINA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 380 TABLE 583 CHINA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 381 TABLE 584 CHINA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 381 TABLE 585 CHINA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 381 TABLE 586 CHINA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 382 TABLE 587 CHINA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 382 TABLE 588 CHINA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 383 TABLE 589 CHINA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 383 TABLE 590 JAPAN: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 384 TABLE 591 JAPAN: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 384 TABLE 592 JAPAN: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 385 TABLE 593 JAPAN: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 385 TABLE 594 JAPAN: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 385 TABLE 595 JAPAN: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 386 TABLE 596 JAPAN: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 386 TABLE 597 JAPAN: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 386 TABLE 598 JAPAN: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 387 TABLE 599 JAPAN: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 387 TABLE 600 JAPAN: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 387 TABLE 601 JAPAN: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 388 TABLE 602 JAPAN: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 388 TABLE 603 JAPAN: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 389 TABLE 604 JAPAN: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 389 TABLE 605 INDIA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 390 TABLE 606 INDIA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 390 TABLE 607 INDIA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 391 TABLE 608 INDIA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 391 TABLE 609 INDIA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 391 TABLE 610 INDIA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 392 TABLE 611 INDIA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 392 TABLE 612 INDIA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 392 TABLE 613 INDIA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 393 TABLE 614 INDIA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 393 TABLE 615 INDIA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 393 TABLE 616 INDIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 394 TABLE 617 INDIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 394 TABLE 618 INDIA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 395 TABLE 619 INDIA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 395 TABLE 620 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 396 TABLE 621 SOUTH KOREA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 396 TABLE 622 SOUTH KOREA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 397 TABLE 623 SOUTH KOREA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 397 TABLE 624 SOUTH KOREA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 397 TABLE 625 SOUTH KOREA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 398 TABLE 626 SOUTH KOREA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 398 TABLE 627 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 398 TABLE 628 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 399 TABLE 629 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 399 TABLE 630 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 399 TABLE 631 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 400 TABLE 632 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 400 TABLE 633 SOUTH KOREA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 401 TABLE 634 SOUTH KOREA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 401 TABLE 635 AUSTRALIA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 402 TABLE 636 AUSTRALIA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 402 TABLE 637 AUSTRALIA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 403 TABLE 638 AUSTRALIA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 403 TABLE 639 AUSTRALIA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 403 TABLE 640 AUSTRALIA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 404 TABLE 641 AUSTRALIA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 404 TABLE 642 AUSTRALIA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 404 TABLE 643 AUSTRALIA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 405 TABLE 644 AUSTRALIA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 405 TABLE 645 AUSTRALIA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 405 TABLE 646 AUSTRALIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 406 TABLE 647 AUSTRALIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 406 TABLE 648 AUSTRALIA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 407 TABLE 649 AUSTRALIA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 407 TABLE 650 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 408 TABLE 651 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 408 TABLE 652 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 409 TABLE 653 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 409 TABLE 654 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 409 TABLE 655 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 410 TABLE 656 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 410 TABLE 657 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 410 TABLE 658 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 411 TABLE 659 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 411 TABLE 660 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 411 TABLE 661 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 412 TABLE 662 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTICS, BY MOLECULE, 2022–2029 (USD MILLION) 412 TABLE 663 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 413 TABLE 664 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 413 TABLE 665 KEY MACROECONOMIC INDICATORS FOR LATIN AMERICA 414 TABLE 666 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 415 TABLE 667 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 415 TABLE 668 LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 415 TABLE 669 LATIN AMERICA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 416 TABLE 670 LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 416 TABLE 671 LATIN AMERICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 416 TABLE 672 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY TYPE, 2022–2029 (USD MILLION) 417 TABLE 673 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 417 TABLE 674 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 417 TABLE 675 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 418 TABLE 676 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 418 TABLE 677 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 418 TABLE 678 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 419 TABLE 679 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 419 TABLE 680 LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 420 TABLE 681 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 420 TABLE 682 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 421 TABLE 683 BRAZIL: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 421 TABLE 684 BRAZIL: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 422 TABLE 685 BRAZIL: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 422 TABLE 686 BRAZIL: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 422 TABLE 687 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022–2029 (USD MILLION) 423 TABLE 688 BRAZIL: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 423 TABLE 689 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 423 TABLE 690 BRAZIL: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 424 TABLE 691 BRAZIL: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 424 TABLE 692 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 424 TABLE 693 BRAZIL: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 425 TABLE 694 BRAZIL: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 425 TABLE 695 BRAZIL: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 426 TABLE 696 BRAZIL: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 426 TABLE 697 MEXICO: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 427 TABLE 698 MEXICO: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 427 TABLE 699 MEXICO: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 428 TABLE 700 MEXICO: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 428 TABLE 701 MEXICO: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 428 TABLE 702 MEXICO: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022–2029 (USD MILLION) 429 TABLE 703 MEXICO: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 429 TABLE 704 MEXICO: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 429 TABLE 705 MEXICO: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 430 TABLE 706 MEXICO: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 430 TABLE 707 MEXICO: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 430 TABLE 708 MEXICO: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 431 TABLE 709 MEXICO: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 431 TABLE 710 MEXICO: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 432 TABLE 711 MEXICO: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 432 TABLE 712 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 433 TABLE 713 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 433 TABLE 714 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 433 TABLE 715 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 434 TABLE 716 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 434 TABLE 717 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022–2029 (USD MILLION) 434 TABLE 718 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 435 TABLE 719 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 435 TABLE 720 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 435 TABLE 721 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 436 TABLE 722 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 436 TABLE 723 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 436 TABLE 724 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 437 TABLE 725 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 437 TABLE 726 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 438 TABLE 727 KEY MACROECONOMIC INDICATORS FOR MIDDLE EAST 439 TABLE 728 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY REGION, 2022–2029 (USD MILLION) 439 TABLE 729 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 439 TABLE 730 MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 440 TABLE 731 MIDDLE EAST: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 440 TABLE 732 MIDDLE EAST: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 440 TABLE 733 MIDDLE EAST: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 441 TABLE 734 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022–2029 (USD MILLION) 441 TABLE 735 MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 441 TABLE 736 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 442 TABLE 737 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 442 TABLE 738 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 442 TABLE 739 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 443 TABLE 740 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 443 TABLE 741 MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 443 TABLE 742 MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 444 TABLE 743 MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 444 TABLE 744 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 445 TABLE 745 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 445 TABLE 746 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 446 TABLE 747 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 446 TABLE 748 GCC COUNTRIES: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 446 TABLE 749 GCC COUNTRIES: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 447 TABLE 750 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022–2029 (USD MILLION) 447 TABLE 751 GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 447 TABLE 752 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 448 TABLE 753 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 448 TABLE 754 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 448 TABLE 755 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 449 TABLE 756 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 449 TABLE 757 GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 449 TABLE 758 GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 450 TABLE 759 GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 450 TABLE 760 SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 451 TABLE 761 SAUDI ARABIA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 451 TABLE 762 SAUDI ARABIA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 452 TABLE 763 SAUDI ARABIA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 452 TABLE 764 SAUDI ARABIA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 452 TABLE 765 SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022–2029 (USD MILLION) 453 TABLE 766 SAUDI ARABIA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 453 TABLE 767 SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 453 TABLE 768 SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHOD, BY TYPE, 2022–2029 (USD MILLION) 454 TABLE 769 SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 454 TABLE 770 SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 454 TABLE 771 SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 455 TABLE 772 SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 455 TABLE 773 SAUDI ARABIA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 456 TABLE 774 SAUDI ARABIA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 456 TABLE 775 UAE: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 457 TABLE 776 UAE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 457 TABLE 777 UAE: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 458 TABLE 778 UAE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 458 TABLE 779 UAE: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 458 TABLE 780 UAE: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022–2029 (USD MILLION) 459 TABLE 781 UAE: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 459 TABLE 782 UAE: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 459 TABLE 783 UAE: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 460 TABLE 784 UAE: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 460 TABLE 785 UAE: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 460 TABLE 786 UAE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 461 TABLE 787 UAE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 461 TABLE 788 UAE: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 462 TABLE 789 UAE: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 462 TABLE 790 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 463 TABLE 791 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 463 TABLE 792 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 464 TABLE 793 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 464 TABLE 794 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 464 TABLE 795 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022–2029 (USD MILLION) 465 TABLE 796 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 465 TABLE 797 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 465 TABLE 798 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 466 TABLE 799 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 466 TABLE 800 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 466 TABLE 801 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 467 TABLE 802 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 467 TABLE 803 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 468 TABLE 804 REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 468 TABLE 805 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 469 TABLE 806 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 469 TABLE 807 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 470 TABLE 808 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 470 TABLE 809 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 470 TABLE 810 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022–2029 (USD MILLION) 471 TABLE 811 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 471 TABLE 812 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 471 TABLE 813 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 472 TABLE 814 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 472 TABLE 815 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 472 TABLE 816 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 473 TABLE 817 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 473 TABLE 818 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 474 TABLE 819 REST OF MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 474 TABLE 820 KEY MACROECONOMIC INDICATORS FOR AFRICA 476 TABLE 821 AFRICA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION) 476 TABLE 822 AFRICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 476 TABLE 823 AFRICA: PEPTIDE SYNTHESIS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 477 TABLE 824 AFRICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 477 TABLE 825 AFRICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 477 TABLE 826 AFRICA: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022–2029 (USD MILLION) 478 TABLE 827 AFRICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 478 TABLE 828 AFRICA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 478 TABLE 829 AFRICA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 479 TABLE 830 AFRICA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION) 479 TABLE 831 AFRICA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 479 TABLE 832 AFRICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 480 TABLE 833 AFRICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 480 TABLE 834 AFRICA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION) 481 TABLE 835 AFRICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION) 481 TABLE 836 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2021–2025 483 TABLE 837 PEPTIDE SYNTHESIS MARKET: DEGREE OF COMPETITION 486 TABLE 838 PEPTIDE SYNTHESIS MARKET: REGION FOOTPRINT 492 TABLE 839 PEPTIDE SYNTHESIS MARKET: OFFERING FOOTPRINT 493 TABLE 840 PEPTIDE SYNTHESIS MARKET: TECHNIQUE FOOTPRINT 494 TABLE 841 PEPTIDE SYNTHESIS MARKET: APPLICATION FOOTPRINT 495 TABLE 842 PEPTIDE SYNTHESIS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 498 TABLE 843 PEPTIDE SYNTHESIS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 499 TABLE 844 PEPTIDE SYNTHESIS MARKET: PRODUCT LAUNCHES, JANUARY 2021–DECEMBER 2024 500 TABLE 845 PEPTIDE SYNTHESIS MARKET: DEALS, JANUARY 2021–DECEMBER 2024 501 TABLE 846 PEPTIDE SYNTHESIS MARKET: EXPANSIONS, JANUARY 2021–DECEMBER 2024 502 TABLE 847 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 503 TABLE 848 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED 505 TABLE 849 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2021−DECEMBER 2024 506 TABLE 850 MERCK KGAA: COMPANY OVERVIEW 507 TABLE 851 MERCK KGAA: PRODUCTS/SERVICES OFFERED 508 TABLE 852 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 512 TABLE 853 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED 513 TABLE 854 GENSCRIPT: COMPANY OVERVIEW 515 TABLE 855 GENSCRIPT: PRODUCTS/SERVICES OFFERED 516 TABLE 856 GENSCRIPT: EXPANSIONS, JANUARY 2021−DECEMBER 2024 517 TABLE 857 KANEKA CORPORATION: COMPANY OVERVIEW 519 TABLE 858 KANEKA CORPORATION: PRODUCTS/SERVICES OFFERED 520 TABLE 859 KANEKA CORPORATION: EXPANSIONS, JANUARY 2021−DECEMBER 2024 521 TABLE 860 BACHEM: COMPANY OVERVIEW 522 TABLE 861 BACHEM: PRODUCTS/SERVICES OFFERED 523 TABLE 862 BACHEM: DEALS, JANUARY 2021−DECEMBER 2024 524 TABLE 863 SYNGENE INTERNATIONAL LIMITED: COMPANY OVERVIEW 525 TABLE 864 SYNGENE INTERNATIONAL LIMITED: PRODUCTS/SERVICES OFFERED 526 TABLE 865 MESA LABS, INC.: COMPANY OVERVIEW 527 TABLE 866 MESA LABS, INC.: PRODUCTS/SERVICES OFFERED 528 TABLE 867 MESA LABS, INC.: PRODUCT LAUNCHES, JANUARY 2021−DECEMBER 2024 529 TABLE 868 MESA LABS, INC.: DEALS, JANUARY 2021−DECEMBER 2024 529 TABLE 869 BIOTAGE: COMPANY OVERVIEW 530 TABLE 870 BIOTAGE: PRODUCTS/SERVICES OFFERED 532 TABLE 871 CEM CORPORATION: COMPANY OVERVIEW 533 TABLE 872 CEM CORPORATION: PRODUCTS/SERVICES OFFERED 533 TABLE 873 CEM CORPORATION: PRODUCT LAUNCHES, JANUARY 2021−DECEMBER 2024 534 TABLE 874 CEM CORPORATION: DEALS, JANUARY 2021−DECEMBER 2024 534 TABLE 875 DALTON PHARMA SERVICES: COMPANY OVERVIEW 535 TABLE 876 DALTON PHARMA SERVICES: PRODUCTS/SERVICES OFFERED 535 TABLE 877 BIO-SYNTHESIS INC.: COMPANY OVERVIEW 536 TABLE 878 BIO-SYNTHESIS INC.: PRODUCTS/SERVICES OFFERED 537 TABLE 879 CSBIO: COMPANY OVERVIEW 538 TABLE 880 CSBIO: PRODUCTS/SERVICES OFFERED 538 TABLE 881 PROTEOGENIX: COMPANY OVERVIEW 539 TABLE 882 PROTEOGENIX: PRODUCTS/SERVICES OFFERED 539 TABLE 883 INNOVAGEN AB: COMPANY OVERVIEW 540 TABLE 884 INNOVAGEN AB: PRODUCTS/SERVICES OFFERED 540 TABLE 885 BIOSYNTH: COMPANY OVERVIEW 541 TABLE 886 BIOSYNTH: PRODUCTS/SERVICES OFFERED 541 TABLE 887 BIOSYNTH: DEALS, JANUARY 2021−DECEMBER 2024 542 TABLE 888 AURIGENE PHARMACEUTICAL SERVICES LTD.: COMPANY OVERVIEW 543 TABLE 889 CORDENPHARMA: COMPANY OVERVIEW 544 TABLE 890 JPT PEPTIDE TECHNOLOGIES: COMPANY OVERVIEW 545 TABLE 891 PUROLITE: COMPANY OVERVIEW 546 TABLE 892 BIOMATIK: COMPANY OVERVIEW 547 TABLE 893 CPC SCIENTIFIC INC.: COMPANY OVERVIEW 548 TABLE 894 ADVANCED CHEMTECH, INC.: COMPANY OVERVIEW 549 TABLE 895 AMBIOPHARM INC.: COMPANY OVERVIEW 550 TABLE 896 LUXEMBOURG BIO TECHNOLOGIES: COMPANY OVERVIEW 551 TABLE 897 AAPPTEC: COMPANY OVERVIEW 552 TABLE 898 ANYGEN: COMPANY OVERVIEW 553 TABLE 899 CHEMPEP: COMPANY OVERVIEW 554 TABLE 900 PROTEOGENIX: COMPANY OVERVIEW 555 FIGURE 1 PEPTIDE SYNTHESIS MARKET SEGMENTATION 55 FIGURE 2 PEPTIDE SYNTHESIS MARKET: RESEARCH DESIGN 59 FIGURE 3 PEPTIDE SYNTHESIS MARKET: BREAKDOWN OF PRIMARY INTERVIEWS 61 FIGURE 4 PEPTIDE SYNTHESIS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023 62 FIGURE 5 GLOBAL MARKET SIZE ESTIMATION APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023 63 FIGURE 6 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2023 63 FIGURE 7 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 65 FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 65 FIGURE 9 PEPTIDE SYNTHESIS MARKET: CAGR PROJECTIONS 67 FIGURE 10 DATA TRIANGULATION METHODOLOGY 69 FIGURE 11 PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION) 72 FIGURE 12 PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 73 FIGURE 13 PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024 VS. 2029 (USD MILLION) 73 FIGURE 14 PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 74 FIGURE 15 PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 75 FIGURE 16 PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 75 FIGURE 17 PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 76 FIGURE 18 GEOGRAPHICAL SNAPSHOT OF PEPTIDE SYNTHESIS MARKET, 2024–2029 77 FIGURE 19 EXPANDING APPLICATIONS OF PEPTIDES IN DIAGNOSTICS, THERAPEUTICS, AND VACCINES TO DRIVE MARKET 78 FIGURE 20 CONSUMABLES SEGMENT AND US LED NORTH AMERICAN MARKET IN 2023 79 FIGURE 21 PRODUCTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 79 FIGURE 22 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 80 FIGURE 23 PEPTIDE SYNTHESIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 81 FIGURE 24 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 87 FIGURE 25 AVERAGE SELLING PRICE OF PEPTIDE SYNTHESIS PRODUCTS, BY KEY PLAYER, 2024 89 FIGURE 26 AVERAGE SELLING PRICE TREND OF PEPTIDE SYNTHESIS PRODUCTS, BY TYPE, 2022–2024 90 FIGURE 27 AVERAGE SELLING PRICE TREND OF PEPTIDE SYNTHESIS PRODUCTS, BY REGION, 2024 92 FIGURE 28 PEPTIDE SYNTHESIS MARKET: SUPPLY CHAIN ANALYSIS 93 FIGURE 29 PEPTIDE SYNTHESIS MARKET: VALUE CHAIN ANALYSIS 95 FIGURE 30 PEPTIDE SYNTHESIS MARKET: ECOSYSTEM ANALYSIS 97 FIGURE 31 PEPTIDE SYNTHESIS MARKET: PATENT ANALYSIS, 2014−2024 103 FIGURE 32 PEPTIDE SYNTHESIS MARKET: PORTER’S FIVE FORCES ANALYSIS 114 FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PEPTIDE SYNTHESIS PRODUCTS 116   FIGURE 34 KEY BUYING CRITERIA FOR PEPTIDE SYNTHESIS PRODUCTS, BY END USER 117 FIGURE 35 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET SNAPSHOT 309 FIGURE 36 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET SNAPSHOT 371 FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN PEPTIDE SYNTHESIS MARKET, 2019–2023 484 FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PEPTIDE SYNTHESIS MARKET, 2023 485 FIGURE 39 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025 487 FIGURE 40 EV/EBITDA OF KEY VENDORS, 2025 487 FIGURE 41 PEPTIDE SYNTHESIS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 488 FIGURE 42 PEPTIDE SYNTHESIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 490 FIGURE 43 PEPTIDE SYNTHESIS MARKET: COMPANY FOOTPRINT 491 FIGURE 44 PEPTIDE SYNTHESIS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 497 FIGURE 45 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023) 504 FIGURE 46 MERCK KGAA: COMPANY SNAPSHOT (2023) 508 FIGURE 47 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023) 513 FIGURE 48 GENSCRIPT: COMPANY SNAPSHOT (2023) 516 FIGURE 49 KANEKA CORPORATION: COMPANY SNAPSHOT (2023) 520 FIGURE 50 BACHEM: COMPANY SNAPSHOT (2023) 523 FIGURE 51 SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2023) 525 FIGURE 52 MESA LABS, INC.: COMPANY SNAPSHOT (2023) 528 FIGURE 53 BIOTAGE: COMPANY SNAPSHOT (2023) 531

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們